Zhiping Cao Selected Research

12-(3-adamantan-1-ylureido)dodecanoic acid butyl ester

11/2008

Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiping Cao Research Topics

Disease

5	Ischemia 01/2020 - 09/2003
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 04/2005
2	Reperfusion Injury 01/2018 - 11/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Myocardial Infarction 12/2021
1	No-Reflow Phenomenon 12/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2020
1	Angina Pectoris 01/2020
1	Neoplasms (Cancer) 02/2016
1	Hypoxia (Hypoxemia) 01/2008
1	Infarction (Infarctions) 04/2005

Drug/Important Bio-Agent (IBA)

2	Collagenases (Collagenase)FDA Link 01/2008 - 04/2005
1	EicosanoidsIBA 01/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020
1	Dobutamine FDA LinkGeneric 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Ranolazine FDA Link 01/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2018
1	AmidophosphoribosyltransferaseIBA 02/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2016
1	12-(3-adamantan-1-ylureido)dodecanoic acid butyl esterIBA 11/2008
1	14,15-epoxy-5,8,11-eicosatrienoic acidIBA 11/2008
1	Arachidonic Acid (Vitamin F)IBA 11/2008
1	Epoxide HydrolasesIBA 11/2008
1	EstersIBA 11/2008
1	AcidsIBA 11/2008
1	Methionine EnkephalinIBA 04/2005
1	barbituric acid (barbiturate)IBA 04/2005
1	Peptides (Polypeptides)IBA 04/2005
1	Propidium (Propidium Iodide)IBA 04/2005
1	Opioid Peptides (Opioid Peptide)IBA 09/2003

Therapy/Procedure

1	Therapeutics 01/2022
1	Aftercare (After-Treatment) 12/2021